Diabetic neuropathy and retinopathy are associated with a higher risk for moderate/severe periodontitis. Dyslipidemia further increases this risk, highlighting the need for comprehensive management in ...

WALTHAM, Mass.--(BUSINESS WIRE)--Regenacy Pharmaceuticals Inc, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, announced ...

A Medicare cohort study of nearly 4 million older patients with type 2 diabetes found 2 in 1000 developed nonarteritic anterior ischemic optic neuropathy (NAION) over a period of more than 3 years.